Global /United Kingdom /Healthcare /Drug Manufacturers - General /EAH

ECO Animal Health Group plc

EAH

• LSE: EAH • Delayed

94GBX 3.1%

1.26 USD

As of 11 June 2026, ECO Animal Health Group plc has a market cap of $84.31M USD, ranking #26738 globally and #609 in the United Kingdom. It ranks #2394 in the Healthcare sector, and #863 in the Drug Manufacturers - General industry.

Global Rank

26738

Country Rank

609

Sector Rank

2394

Industry Rank

863

Key Stats

Market Cap

$84.31MUSD

63.02M GBP

Enterprise Value

$76.41MUSD

57.08M GBP

Revenue (TTM)

$114.82MUSD

85.81M GBP

EBITDA (TTM)

$11.93MUSD

8.91M GBP

Net Income (TTM)

$4.04MUSD

3.02M GBP

EBITDA Margin

10%

Profit Margin

3.5%

PE Ratio

21.4

Forward PE

31.2

PS Ratio

0.7

PB Ratio

0.7

EV/EBITDA

5.9

Company Profile

Country (HQ)

United Kingdom

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

David Hallas open_in_new

Employees

200

Founded

1972

Website

ecoanimalhealth.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
3.1%	-4%	-6.4%	-12%	10%	-12%	41%	-24%	-75%

Upcoming Earnings

Earnings Date

Fri, Jul 10

News

Markets

Exchange	Ticker	Price	Quotes
London Stock Exchange (LSE / LON) MIC: XLON PRIMARY	EAH Eco Animal Health Group PLC ISIN: GB0032036807 Shares Out.: Shares Outstanding: 67.76M¹ Shares Float: 60.293M² TV: TradingView: LSE: EAH SA: Stock Analysis: LON: EAH YF: Yahoo Finance: EAH.L GF: Google Finance: LON: EAH BA: Barron's: EAH MS: Morningstar: XLON: EAH	94 GBX	TV: TradingView: LSE: EAH SA: Stock Analysis: LON: EAH YF: Yahoo Finance: EAH.L GF: Google Finance: LON: EAH BA: Barron's: EAH MS: Morningstar: XLON: EAH

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About ECO Animal Health Group plc

ECO Animal Health Group plc, together with its subsidiaries, manufactured and supply animal health products internationally. The company provides Aivlosin, a macrolide antibiotic for the treatment of enteric and respiratory diseases in pigs and poultry. It also offers generic drugs, such as Ecomectin, Ecoheart, Ecotraz, and Ecomintic, which are endectocides and other antiparasitics for the treatment and prevention of parasites in cattle, sheep, pigs, horses, and dogs; and Chlortetracycline and Oxytetracycline for treatment of bacterial infections in pigs, poultry, and cattle. ECO Animal Health Group plc was founded in 1972 and is based in London, the United Kingdom.

Similar Companies

Industry: Drug Manufacturers - General (United Kingdom)

Name	Market Cap (USD) diff.	PE	Country
AstraZeneca PLC LSE: AZN	$288.45B 215.59B GBP 342K%	27.6	United Kingdom
GSK plc LSE: GSK	$108.32B 80.96B GBP 128K%	14.6	United Kingdom
Haleon plc LSE: HLN	$41.77B 31.22B GBP 49K%	19.0	United Kingdom
Roivant Sciences Ltd. NASDAQ: ROIV	$19.69B 23K%	-	United Kingdom
Centessa Pharmaceuticals plc NASDAQ: CNTA	$6.1B 7K%	-	United Kingdom
Kiniksa Pharmaceuticals International, plc NASDAQ: KNSA	$4.07B 5K%	58.4	United Kingdom

Industry: Drug Manufacturers - General (Global)

Name	Market Cap (USD) diff.	PE	Country
Eli Lilly and Co. NYSE: LLY	$761.68B 903K%	38.1	United States
Johnson & Johnson NYSE: JNJ	$547.28B 649K%	26.4	United States
AbbVie Inc. NYSE: ABBV	$360.63B 428K%	97.4	United States
Roche Holding AG SIX: RO	$320.56B 256.25B CHF 380K%	19.9	Switzerland
Merck & Co., Inc. NYSE: MRK	$274.03B 325K%	15.1	United States
Novartis AG SIX: NOVN	$273.83B 218.9B CHF 325K%	20.5	Switzerland

chevron_leftBack